Register | Log in | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

djmonstermo's cancer [38 articles]

Recent papers added to djmonstermo's library classified by the tag cancer. You can also see everyone's cancer.
  • Clinical practice. The solitary pulmonary nodule.
    The New England journal of medicine, Vol. 348, No. 25. (19 June 2003), pp. 2535-2542.
    by D Ost, AM Fein, SH Feinsilver
    posted to cancer by djmonstermo on 2008-09-17 06:00:10 as **
  • Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd Edition).
    Chest, Vol. 132, No. 3 Suppl. (September 2007)
    by WM Alberts,
    posted to cancer by djmonstermo on 2008-07-18 23:58:51 as **
  • Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
    The New England journal of medicine, Vol. 350, No. 23. (3 June 2004), pp. 2343-2351.
    by T André, C Boni, L Mounedji-Boudiaf, M Navarro, J Tabernero, T Hickish, C Topham, M Zaninelli, P Clingan, J Bridgewater, I Tabah-Fisch, A de Gramont,
    posted to cancer by djmonstermo on 2008-07-12 05:18:45 as **
  • Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.
    The New England journal of medicine, Vol. 351, No. 4. (22 July 2004), pp. 337-345.
    by D Cunningham, Y Humblet, S Siena, D Khayat, H Bleiberg, A Santoro, D Bets, M Mueser, A Harstrick, C Verslype, I Chau, E Van Cutsem
    posted to cancer by djmonstermo on 2008-07-12 05:16:13 as ** along with 1 person frohike
  • Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.
    The New England journal of medicine, Vol. 343, No. 13. (28 September 2000), pp. 905-914.
    by LB Saltz, JV Cox, C Blanke, LS Rosen, L Fehrenbacher, MJ Moore, JA Maroun, SP Ackland, PK Locker, N Pirotta, GL Elfring, LL Miller
    posted to cancer by djmonstermo on 2008-07-12 05:15:57 as **
  • Lessons from hereditary colorectal cancer.
    Cell, Vol. 87, No. 2. (18 October 1996), pp. 159-170.
    by KW Kinzler, B Vogelstein
    posted to cancer by djmonstermo on 2008-07-12 05:14:46 as ** along with 1 person gwenknight
  • Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
    The New England journal of medicine, Vol. 353, No. 10. (8 September 2005), pp. 977-987.
    by G Bucaneve, A Micozzi, F Menichetti, P Martino, MS Dionisi, G Martinelli, B Allione, D D'Antonio, M Buelli, AM Nosari, D Cilloni, E Zuffa, R Cantaffa, G Specchia, S Amadori, F Fabbiano, GL Deliliers, F Lauria, R Foà, A Del Favero,
    posted to cancer id by djmonstermo on 2008-07-11 05:05:50 as **
  • A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    The New England journal of medicine, Vol. 341, No. 5. (29 July 1999), pp. 305-311.
    by A Freifeld, D Marchigiani, T Walsh, S Chanock, L Lewis, J Hiemenz, S Hiemenz, JE Hicks, V Gill, SM Steinberg, PA Pizzo
    posted to cancer id by djmonstermo on 2008-07-11 05:04:53 as **
  • A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
    The New England journal of medicine, Vol. 331, No. 20. (17 November 1994), pp. 1325-1330.
    by JH Rex, JE Bennett, AM Sugar, PG Pappas, CM van der Horst, JE Edwards, RG Washburn, WM Scheld, AW Karchmer, AP Dine
    posted to cancer id by djmonstermo on 2008-07-11 05:03:10 as **
  • Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    The New England journal of medicine, Vol. 340, No. 10. (11 March 1999), pp. 764-771.
    by TJ Walsh, RW Finberg, C Arndt, J Hiemenz, C Schwartz, D Bodensteiner, P Pappas, N Seibel, RN Greenberg, S Dummer, M Schuster, JS Holcenberg
    posted to cancer id by djmonstermo on 2008-07-11 05:01:07 as **
  • Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    N Engl J Med, Vol. 351, No. 14. (30 September 2004), pp. 1391-1402.
    by TJ Walsh, H Teppler, GR Donowitz, JA Maertens, LR Baden, A Dmoszynska, OA Cornely, MR Bourque, RJ Lupinacci, CA Sable, BE dePauw
    posted to cancer id by djmonstermo on 2008-07-11 04:59:04 as ** along with 1 person brainsman2000
  • Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    N Engl J Med, Vol. 346, No. 4. (24 January 2002), pp. 225-234.
    by TJ Walsh, P Pappas, DJ Winston, HM Lazarus, F Petersen, J Raffalli, S Yanovich, P Stiff, R Greenberg, G Donowitz, M Schuster, A Reboli, J Wingard, C Arndt, J Reinhardt, S Hadley, R Finberg, M Laverdière, J Perfect, G Garber, G Fioritoni, E Anaissie, J Lee,
    posted to cancer id by djmonstermo on 2008-07-11 04:58:40 as ** along with 1 person brainsman2000
  • Management of fever in patients with cancer and treatment-induced neutropenia.
    The New England journal of medicine, Vol. 328, No. 18. (6 May 1993), pp. 1323-1332.
    by PA Pizzo
    posted to cancer id by djmonstermo on 2008-07-11 04:58:26 as **
  • Paraneoplastic syndromes involving the nervous system.
    The New England journal of medicine, Vol. 349, No. 16. (16 October 2003), pp. 1543-1554.
    by RB Darnell, JB Posner
    posted to cancer by djmonstermo on 2008-07-11 04:55:57 as **
  • Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia.
    The New England journal of medicine, Vol. 323, No. 25. (20 December 1990), pp. 1729-1735.
    by GJ Anhalt, SC Kim, JR Stanley, NJ Korman, DA Jabs, M Kory, H Izumi, H Ratrie, D Mutasim, L Ariss-Abdo
    posted to cancer by djmonstermo on 2008-07-11 04:55:09 as **
  • Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    The New England journal of medicine, Vol. 332, No. 22. (1 June 1995), pp. 1467-1474.
    by VA Lennon, TJ Kryzer, GE Griesmann, PE O'Suilleabhain, AJ Windebank, A Woppmann, GP Miljanich, EH Lambert
    posted to cancer by djmonstermo on 2008-07-11 04:54:46 as **
  • Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 21, No. 1. (1 January 2003), pp. 60-65.
    by F Kabbinavar, HI Hurwitz, L Fehrenbacher, NJ Meropol, WF Novotny, G Lieberman, S Griffing, E Bergsland
    posted to cancer by djmonstermo on 2008-07-11 04:51:18 as **
  • Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.
    Nature medicine, Vol. 10, No. 2. (February 2004), pp. 145-147.
    by CG Willett, Y Boucher, E di Tomaso, DG Duda, LL Munn, RT Tong, DC Chung, DV Sahani, SP Kalva, SV Kozin, M Mino, KS Cohen, DT Scadden, AC Hartford, AJ Fischman, JW Clark, DP Ryan, AX Zhu, LS Blaszkowsky, HX Chen, PC Shellito, GY Lauwers, RK Jain
    posted to cancer by djmonstermo on 2008-07-11 04:51:04 as **
  • A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.
    The New England journal of medicine, Vol. 349, No. 5. (31 July 2003), pp. 427-434.
    by JC Yang, L Haworth, RM Sherry, P Hwu, DJ Schwartzentruber, SL Topalian, SM Steinberg, HX Chen, SA Rosenberg
    posted to cancer by djmonstermo on 2008-07-11 04:50:10 as **
  • Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.
    N Engl J Med, Vol. 350, No. 23. (3 June 2004), pp. 2335-2342.
    by H Hurwitz, L Fehrenbacher, W Novotny, T Cartwright, J Hainsworth, W Heim, J Berlin, A Baron, S Griffing, E Holmgren, N Ferrara, G Fyfe, B Rogers, R Ross, F Kabbinavar
    posted to cancer by djmonstermo on 2008-07-11 04:49:54 as ** along with 1 person dbs
  • The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
    JAMA : the journal of the American Medical Association, Vol. 281, No. 23. (16 June 1999), pp. 2189-2197.
    by SR Cummings, S Eckert, KA Krueger, D Grady, TJ Powles, JA Cauley, L Norton, T Nickelsen, NH Bjarnason, M Morrow, ME Lippman, D Black, JE Glusman, A Costa, VC Jordan
    posted to cancer wh by djmonstermo on 2008-07-11 04:48:11 as ** along with 1 person jclau
  • Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.
    N Engl J Med, Vol. 355, No. 2. (13 July 2006), pp. 125-137.
    by E Barrett-Connor, L Mosca, P Collins, MJ Geiger, D Grady, M Kornitzer, MA McNabb, NK Wenger,
    posted to cancer wh by djmonstermo on 2008-07-11 04:47:25 as ** along with 1 person guardian077
  • HER2 and response to paclitaxel in node-positive breast cancer.
    The New England journal of medicine, Vol. 357, No. 15. (11 October 2007), pp. 1496-1506.
    by DF Hayes, AD Thor, LG Dressler, D Weaver, S Edgerton, D Cowan, G Broadwater, LJ Goldstein, S Martino, JN Ingle, IC Henderson, L Norton, EP Winer, CA Hudis, MJ Ellis, DA Berry,
    posted to cancer by djmonstermo on 2008-07-11 04:46:50 as **
  • Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
    The New England journal of medicine, Vol. 357, No. 26. (27 December 2007), pp. 2666-2676.
    by K Miller, M Wang, J Gralow, M Dickler, M Cobleigh, EA Perez, T Shenkier, D Cella, NE Davidson
    posted to cancer by djmonstermo on 2008-07-11 04:46:11 as **
  • Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
    J Natl Cancer Inst, Vol. 90, No. 18. (16 September 1998), pp. 1371-1388.
    by B Fisher, JP Costantino, DL Wickerham, CK Redmond, M Kavanah, WM Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins, M Daly, S Wieand, E Tan-Chiu, L Ford, N Wolmark
    posted to cancer by djmonstermo on 2008-07-11 04:44:02 as ** along with 2 people dbs igorccampos
  • Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.
    JAMA : the journal of the American Medical Association, Vol. 286, No. 18. (14 November 2001), pp. 2251-2256.
    by MC King, S Wieand, K Hale, M Lee, T Walsh, K Owens, J Tait, L Ford, BK Dunn, J Costantino, L Wickerham, N Wolmark, B Fisher,
    posted to cancer by djmonstermo on 2008-07-11 04:43:15 as **
  • Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
    N Engl J Med, Vol. 353, No. 16. (20 October 2005), pp. 1673-1684.
    by EH Romond, EA Perez, J Bryant, VJ Suman, CE Geyer, NE Davidson, E Tan-Chiu, S Martino, S Paik, PA Kaufman, SM Swain, TM Pisansky, L Fehrenbacher, LA Kutteh, VG Vogel, DW Visscher, G Yothers, RB Jenkins, AM Brown, SR Dakhil, EP Mamounas, WL Lingle, PM Klein, JN Ingle, N Wolmark
    posted to cancer by djmonstermo on 2008-07-11 04:34:01 as ** along with 1 person adelgiglio
  • The sentinel node in breast cancer--a multicenter validation study.
    The New England journal of medicine, Vol. 339, No. 14. (1 October 1998), pp. 941-946.
    by D Krag, D Weaver, T Ashikaga, F Moffat, VS Klimberg, C Shriver, S Feldman, R Kusminsky, M Gadd, J Kuhn, S Harlow, P Beitsch
    posted to cancer by djmonstermo on 2008-07-11 04:33:19 as **
  • Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.
    The New England journal of medicine, Vol. 337, No. 14. (2 October 1997), pp. 956-962.
    by J Ragaz, SM Jackson, N Le, IH Plenderleith, JJ Spinelli, VE Basco, KS Wilson, MA Knowling, CM Coppin, M Paradis, AJ Coldman, IA Olivotto
    posted to cancer by djmonstermo on 2008-07-11 04:33:05 as **
  • Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
    N Engl J Med, Vol. 344, No. 11. (15 March 2001), pp. 783-792.
    by DJ Slamon, B Leyland-Jones, S Shak, H Fuchs, V Paton, A Bajamonde, T Fleming, W Eiermann, J Wolter, M Pegram, J Baselga, L Norton
    posted to cancer by djmonstermo on 2008-07-11 04:31:16 as ** along with 1 person adelgiglio
  • Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.
    Science (New York, N.Y.), Vol. 235, No. 4785. (9 January 1987), pp. 177-182.
    by DJ Slamon, GM Clark, SG Wong, WJ Levin, A Ullrich, WL McGuire
    posted to cancer by djmonstermo on 2008-07-11 04:30:53 as **
  • Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
    N Engl J Med, Vol. 353, No. 16. (20 October 2005), pp. 1659-1672.
    by MJ Piccart-Gebhart, M Procter, B Leyland-Jones, A Goldhirsch, M Untch, I Smith, L Gianni, J Baselga, R Bell, C Jackisch, D Cameron, M Dowsett, CH Barrios, G Steger, CS Huang, M Andersson, M Inbar, M Lichinitser, I Láng, U Nitz, H Iwata, C Thomssen, C Lohrisch, TM Suter, J Rüschoff, T Suto, V Greatorex, C Ward, C Straehle, E McFadden, MS Dolci, RD Gelber,
    posted to cancer by djmonstermo on 2008-07-11 04:30:27 as ** along with 1 person adelgiglio
  • The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
    N Engl J Med, Vol. 336, No. 20. (15 May 1997), pp. 1401-1408.
    by JP Struewing, P Hartge, S Wacholder, SM Baker, M Berlin, M McAdams, MM Timmerman, LC Brody, MA Tucker
    posted to cancer by djmonstermo on 2008-07-11 04:28:30 as ** along with 1 person bayesmendel
  • American Cancer Society guidelines for breast cancer screening: update 2003.
    CA: a cancer journal for clinicians, Vol. 53, No. 3. (n 2003), pp. 141-169.
    by RA Smith, D Saslow, KA Sawyer, W Burke, ME Costanza, WP Evans, RS Foster, E Hendrick, HJ Eyre, S Sener, , , , , ,
    posted to cancer by djmonstermo on 2008-07-11 04:27:19 as ** along with 1 person chochoz
  • Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.
    Journal of the National Cancer Institute, Vol. 93, No. 1. (3 January 2001), pp. 31-38.
    by R García-Carbonero, JI Mayordomo, MV Tornamira, M López-Brea, A Rueda, V Guillem, A Arcediano, A Yubero, F Ribera, C Gómez, A Trés, JL Pérez-Gracia, C Lumbreras, J Hornedo, H Cortés-Funes, L Paz-Ares
    posted to cancer by djmonstermo on 2008-07-11 04:25:31 as **
  • Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 16, No. 9. (September 1998), pp. 2930-2936.
    by A Ravaud, C Chevreau, L Cany, P Houyau, N Dohollou, H Roché, P Soubeyran, F Bonichon, J Mihura, H Eghbali, I Tabah, BN Bui
    posted to cancer by djmonstermo on 2008-07-11 04:24:49 as **
  • Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 14, No. 2. (February 1996), pp. 619-627.
    by E Vellenga, CA Uyl-de Groot, R de Wit, HJ Keizer, B Löwenberg, MA ten Haaft, TJ de Witte, CA Verhagen, GJ Stoter, FF Rutten, NH Mulder, WM Smid, EG de Vries
    posted to cancer by djmonstermo on 2008-07-11 04:23:51 as **
  • Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.
    The New England journal of medicine, Vol. 325, No. 3. (18 July 1991), pp. 164-170.
    by J Crawford, H Ozer, R Stoller, D Johnson, G Lyman, I Tabbara, M Kris, J Grous, V Picozzi, G Rausch
    posted to cancer by djmonstermo on 2008-07-11 04:20:23 as **
    • Note: You may cite this page as: http://www.citeulike.org/user/djmonstermo/tag/cancer

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.